Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
Article in Frontiers in Oncology (July 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (July 2023)
Article in Reactions Weekly (April 2023)
Article in Radiotherapy and Oncology (February 2023)